---
title: "301507.SZ (301507.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301507.SZ/news.md"
symbol: "301507.SZ"
name: "301507.SZ"
parent: "https://longbridge.com/en/quote/301507.SZ.md"
datetime: "2026-03-17T13:50:11.459Z"
locales:
  - [en](https://longbridge.com/en/quote/301507.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301507.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301507.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301507.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301507.SZ/news.md)


# 301507.SZ (301507.SZ) — Related News

### [Century Minsheng is expected to earn 5.59 yuan per share in 2025! The "Phoenix Plan 2.0" opens a new growth cycle](https://longbridge.com/en/news/279413288.md)
*2026-03-17T10:35:50.000Z*
> Century Life expects to achieve a consolidated revenue of NT$ 29.83 billion in 2025, a year-on-year increase of 374.78%,

### [MSJK released the brand strategy for Xiao Jin Wei Ta® to focus on the specialized field of children's nutrition](https://longbridge.com/en/news/273674279.md)
*2026-01-26T08:52:02.000Z*
> Against the backdrop of continuous upgrades in the health industry and the accelerated segmentation of children's nutrit

### [MSJK Chen Wenzhu: The consumer medical sector is ushering in structural opportunities, and innovation is the key to breaking the deadlock](https://longbridge.com/en/news/269577187.md)
*2025-12-12T21:41:14.000Z*
> At the 2025 China Meheco Health Industry Forum, MSJK Board Secretary Chen Wenzhu pointed out that the consumer healthcar

### [MSJK: First repurchase of company shares 82,900 shares, accounting for 0.02% of the total share capital](https://longbridge.com/en/news/268928916.md)
*2025-12-08T09:40:42.000Z*
> MSJK announced that on December 5, 2025, the company repurchased 82,900 shares through a dedicated securities repurchase

### [MSJK: The new smoking cessation drug Lesuoke has started pre-sales on online platforms](https://longbridge.com/en/news/266105345.md)
*2025-11-17T01:54:30.000Z*
> MSJK recently stated during discussions with research institutions that its new smoking cessation drug—MSJK Lesu Ke D-ta

### [Overview of A-share Stock Buybacks: 26 Companies Disclose Buyback Progress Today](https://longbridge.com/en/news/263387285.md)
*2025-10-29T23:38:00.000Z*
> On October 30th, 26 companies announced 27 stock repurchase updates, among which 16 companies disclosed their repurchase

### [Exclusive Interview with the General Manager of MSJK: Anchoring on the Big Health Track and Actively Building a Second Growth Curve](https://longbridge.com/en/news/258548630.md)
*2025-09-23T13:52:04.000Z*
> "21 Jinweita, family health, our responsibility," this well-known slogan has brought "21 Jinweita" into thousands of hou

### [MSJK: The market potential of Vaniklan in the domestic market has not been fully developed, and there is significant market potential](https://longbridge.com/en/news/256045787.md)
*2025-09-05T02:02:22.000Z*
> MSJK stated that the potential of varenicline in the domestic market has not been fully developed, and the market size i